Synairgen plc
Synairgen plc discovers and develops drugs for respiratory diseases. It develops SNG001, an inhaled interferon beta for the treatment of severe viral lung infections that is in pre- clinical trial; and inhaled interferon beta IFN-ß, a naturally occurring protein, which orchestrates the body's antiviral responses. Synairgen plc was incorporated in 2004 and is headquartered in Southampton, the Unit… Read more
Synairgen plc (SYGGF) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of December 2024: -0.001x
Based on the latest financial reports, Synairgen plc (SYGGF) has a cash flow conversion efficiency ratio of -0.001x as of December 2024.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-4.12K) by net assets ($6.28 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Synairgen plc - Cash Flow Conversion Efficiency Trend (2003–2024)
This chart illustrates how Synairgen plc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Synairgen plc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Synairgen plc ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Yakkyo S.P.A.
F:IA4
|
N/A |
|
Hanoi Beer Trading JSC
VN:HAT
|
N/A |
|
NBEST Prime VIII Inmuebles Socimi SA
MC:YINB8
|
0.011x |
|
Solid State Plc
LSE:SOLI
|
0.060x |
|
Mister International Enterprise Corp.
TWO:2941
|
-0.028x |
|
Dream Impact Trust
TO:MPCT-UN
|
-0.008x |
|
Good Energy Group PLC
LSE:GOOD
|
0.065x |
|
Caelum Co. Ltd.
KO:258610
|
0.023x |
Annual Cash Flow Conversion Efficiency for Synairgen plc (2003–2024)
The table below shows the annual cash flow conversion efficiency of Synairgen plc from 2003 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | $6.28 Million | $-7.81 Million | -1.244x | -91.55% |
| 2023-12-31 | $12.66 Million | $-8.22 Million | -0.649x | +7.83% |
| 2022-12-31 | $20.27 Million | $-14.29 Million | -0.705x | +36.44% |
| 2021-12-31 | $37.00 Million | $-41.02 Million | -1.109x | -296.25% |
| 2020-12-31 | $85.14 Million | $-23.82 Million | -0.280x | +78.24% |
| 2019-12-31 | $2.25 Million | $-2.90 Million | -1.285x | -102.64% |
| 2018-12-31 | $6.03 Million | $-3.82 Million | -0.634x | -301.28% |
| 2017-12-31 | $6.56 Million | $2.07 Million | 0.315x | +149.41% |
| 2016-12-31 | $4.68 Million | $-2.99 Million | -0.638x | -142.41% |
| 2015-12-31 | $7.35 Million | $-1.93 Million | -0.263x | -237.69% |
| 2014-12-31 | $9.44 Million | $1.80 Million | 0.191x | +116.85% |
| 2013-12-31 | $1.58 Million | $-1.79 Million | -1.134x | -55.55% |
| 2012-12-31 | $3.42 Million | $-2.49 Million | -0.729x | -16.98% |
| 2010-12-31 | $4.23 Million | $-2.64 Million | -0.623x | -52.42% |
| 2009-12-31 | $6.85 Million | $-2.80 Million | -0.409x | -38.97% |
| 2008-12-31 | $8.00 Million | $-2.35 Million | -0.294x | +45.14% |
| 2007-12-31 | $4.19 Million | $-2.25 Million | -0.536x | -96.38% |
| 2006-12-31 | $6.25 Million | $-1.71 Million | -0.273x | -39.92% |
| 2005-12-31 | $7.84 Million | $-1.53 Million | -0.195x | -105.45% |
| 2004-12-31 | $8.84 Million | $-840.00K | -0.095x | +31.29% |
| 2003-12-31 | $470.00K | $-65.00K | -0.138x | -- |